{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:12:02Z","timestamp":1793225522892,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.forsciint.2023.111764","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T14:32:02Z","timestamp":1686839522000},"page":"111764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Driving under the influence of zopiclone: Elimination between two consecutive blood samples"],"prefix":"10.1016","volume":"349","author":[{"given":"Maren Cecilie","family":"Strand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8yvind","family":"Bleka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Kristoffersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"H\u00f8iseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2023.111764_bib1","series-title":"Rang and Dale's Pharmacology","author":"Rang","year":"2016"},{"issue":"2","key":"10.1016\/j.forsciint.2023.111764_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13181-013-0294-y","article-title":"In the Zzz zone: the effects of Z-drugs on human performance and driving","volume":"9","author":"Gunja","year":"2013","journal-title":"J. Med. Toxicol."},{"issue":"4","key":"10.1016\/j.forsciint.2023.111764_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2165\/00003088-200443040-00002","article-title":"Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone","volume":"43","author":"Drover","year":"2004","journal-title":"Clin. Pharmacokinet."},{"issue":"5","key":"10.1016\/j.forsciint.2023.111764_bib4","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.aap.2008.06.015","article-title":"Prevalence of alcohol and drugs among Norwegian motor vehicle drivers: a roadside survey","volume":"40","author":"Gjerde","year":"2008","journal-title":"Accid. Anal. Prev."},{"issue":"10","key":"10.1016\/j.forsciint.2023.111764_bib5","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.5665\/SLEEP.1272","article-title":"Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects","volume":"34","author":"Mets","year":"2011","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.forsciint.2023.111764_bib6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.clinthera.2013.11.005","article-title":"Zopiclone's residual effects on actual driving performance in a standardized test: a pooled analysis of age and sex effects in 4 placebo-controlled studies","volume":"36","author":"Leufkens","year":"2014","journal-title":"Clin. Ther."},{"issue":"2","key":"10.1016\/j.forsciint.2023.111764_bib7","first-page":"79","article-title":"Driving under the influence of non-alcohol drugs--An update. Part II: experimental studies","volume":"28","author":"Strand","year":"2016","journal-title":"Forensic Sci. Rev."},{"issue":"1","key":"10.1016\/j.forsciint.2023.111764_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/15389588.2020.1849643","article-title":"A comparison of driving related skills impaired by ethanol and zopiclone","volume":"22","author":"H\u00f8iseth","year":"2021","journal-title":"Traffic Inj. Prev."},{"issue":"8","key":"10.1016\/j.forsciint.2023.111764_bib9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.sleep.2007.11.011","article-title":"Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam","volume":"9","author":"Gustavsen","year":"2008","journal-title":"Sleep. Med."},{"issue":"9137","key":"10.1016\/j.forsciint.2023.111764_bib10","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0140-6736(98)04087-2","article-title":"Association of road-traffic accidents with benzodiazepine use","volume":"352","author":"Barbone","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.forsciint.2023.111764_bib11","doi-asserted-by":"crossref","unstructured":"Schulze H., Schumacher M., Urmeew R., Alvarez J., Bernhoft I., de Gier H., et al. Driving under the influence of drugs, alcohol and medicines in europe\u2014findings from the DRUID project European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); 2012.","DOI":"10.1093\/eurpub\/ckt126.151"},{"key":"10.1016\/j.forsciint.2023.111764_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.forsciint.2017.07.004","article-title":"Zopiclone concentrations in oral fluid and blood after, administration of therapeutic doses of zopiclone","volume":"278","author":"Hjelmeland","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2023.111764_bib13","unstructured":"American Academy of Forensic Sciences. Guidelines for Opinions and Testimony in Forensic Toxicology 2019 [Available from: https:\/\/www.aafs.org\/asb-standard\/guidelines-opinions-and-testimony-forensic-toxicology."},{"issue":"Suppl 1","key":"10.1016\/j.forsciint.2023.111764_bib14","first-page":"22","article-title":"Comparison of zopiclone pharmacokinetics in patients with impaired renal function and normal subjects. Effect of hemodialysis","volume":"10","author":"Marc-Aurele","year":"1987","journal-title":"Sleep"},{"issue":"6","key":"10.1016\/j.forsciint.2023.111764_bib15","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0090-9556(25)08209-1","article-title":"Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers","volume":"21","author":"Fernandez","year":"1993","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.forsciint.2023.111764_bib16","first-page":"97","article-title":"A repeated dose pharmacokinetic study of a new hypnotic agent, zopiclone (Imovane)","volume":"23","author":"Houghton","year":"1985","journal-title":"Int. J. Clin. Pharmacol., Ther., Toxicol."},{"issue":"Suppl 1","key":"10.1016\/j.forsciint.2023.111764_bib17","first-page":"7","article-title":"Critical factors for pharmacokinetics of zopiclone in the elderly and in patients with liver and renal insufficiency","volume":"10","author":"Gaillot","year":"1987","journal-title":"Sleep"},{"issue":"Suppl 2","key":"10.1016\/j.forsciint.2023.111764_bib18","first-page":"95","article-title":"Steady state pharmacokinetics of zopiclone during multiple oral dosing (7.5 mg nocte) in patients with severe chronic renal failure","volume":"5","author":"Viron","year":"1990","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.forsciint.2023.111764_bib19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2125.1983.tb02159.x","article-title":"Plasma concentrations and central nervous system effects of the new hypnotic agent zopiclone in patients with chronic liver disease","volume":"16","author":"Parker","year":"1983","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.forsciint.2023.111764_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2125.1994.tb04367.x","article-title":"The effect of erythromycin on the pharmacokinetics and pharmacodynamics of zopiclone","volume":"38","author":"Aranko","year":"1994","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.forsciint.2023.111764_bib21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1365-2125.1997.00579.x","article-title":"Concentrations and effects of zopiclone are greatly reduced by rifampicin","volume":"43","author":"Villikka","year":"1997","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3\u20134","key":"10.1016\/j.forsciint.2023.111764_bib22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s002280050207","article-title":"Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zopiclone","volume":"51","author":"Jalava","year":"1996","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.forsciint.2023.111764_bib23","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/jat\/34.9.590","article-title":"Comparison of zopiclone concentrations in oral fluid sampled with Intercept(\u00ae) oral specimen collection device and Statsure Saliva Sampler\u2122 and concentrations in blood","volume":"34","author":"Gjerde","year":"2010","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2023.111764_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jchromb.2014.09.018","article-title":"Quantitative determination of zopiclone and zolpidem in whole blood by liquid-liquid extraction and UHPLC-MS\/MS","volume":"971","author":"Eliassen","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.forsciint.2023.111764_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.forsciint.2015.12.009","article-title":"Determination of safety margins for whole blood concentrations of alcohol and nineteen drugs in driving under the influence cases","volume":"259","author":"Kristoffersen","year":"2016","journal-title":"Forensic Sci. Int."},{"issue":"1","key":"10.1016\/j.forsciint.2023.111764_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1081\/BIP-100101013","article-title":"Why are pharmacokinetic data summarized by arithmetic means","volume":"10","author":"Julious","year":"2000","journal-title":"J. Biopharm. Stat."},{"issue":"12","key":"10.1016\/j.forsciint.2023.111764_bib27","first-page":"2124","article-title":"Zopiclone: is it a pharmacologic agent for abuse?","volume":"53","author":"Cimolai","year":"2007","journal-title":"Can. Fam. Physician"},{"issue":"1\u20133","key":"10.1016\/j.forsciint.2023.111764_bib28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.forsciint.2012.05.008","article-title":"Concentrations of zolpidem and zopiclone in venous blood samples from impaired drivers compared with femoral blood from forensic autopsies","volume":"222","author":"Jones","year":"2012","journal-title":"Forensic Sci. Int."},{"issue":"10","key":"10.1016\/j.forsciint.2023.111764_bib29","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1360-0443.2003.00491.x","article-title":"Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data","volume":"98","author":"Hajak","year":"2003","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.forsciint.2023.111764_bib30","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1600-0773.1996.tb01387.x","article-title":"Pharmacokinetic-pharmacodynamic modelling of zopiclone effects on human central nervous system","volume":"78","author":"Luurila","year":"1996","journal-title":"Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.forsciint.2023.111764_bib31","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-2125.1984.tb02559.x","article-title":"The effect of posture at the time of administration on the central depressant effects of the new hypnotic zopiclone","volume":"18","author":"Channer","year":"1984","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"Suppl 2","key":"10.1016\/j.forsciint.2023.111764_bib32","first-page":"76","article-title":"Pharmacokinetics and metabolism of zopiclone","volume":"17","author":"Gaillot","year":"1982","journal-title":"Int. Pharm."},{"issue":"4","key":"10.1016\/j.forsciint.2023.111764_bib33","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/JCP.0b013e3182214be6","article-title":"Psychomotor performance after intake of zopiclone compared with intake of ethanol: a randomized, controlled, double-blinded trial","volume":"31","author":"Gustavsen","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.forsciint.2023.111764_bib34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.forsciint.2010.04.001","article-title":"Stability tests of zopiclone in whole blood","volume":"200","author":"Nilsson","year":"2010","journal-title":"Forensic Sci. Int."},{"issue":"8","key":"10.1016\/j.forsciint.2023.111764_bib35","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/jat\/bkw084","article-title":"Stability of 26 sedative hypnotics in six toxicological matrices at different storage conditions","volume":"40","author":"Mata","year":"2016","journal-title":"J. Anal. Toxicol."},{"issue":"6","key":"10.1016\/j.forsciint.2023.111764_bib36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4103\/1735-5362.301335","article-title":"Bayesian estimation of pharmacokinetic parameters: an important component to include in the teaching of clinical pharmacokinetics and therapeutic drug monitoring","volume":"15","author":"Brocks","year":"2020","journal-title":"Res. Pharm. Sci."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073823002141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073823002141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T18:13:09Z","timestamp":1759947189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073823002141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":36,"alternative-id":["S0379073823002141"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2023.111764","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Driving under the influence of zopiclone: Elimination between two consecutive blood samples","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2023.111764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111764"}}